THURSDAY, July 1, 2021 (HealthDay News) — An experimental drug can prevent intestinal damage caused by celiac disease, an early trial has found — raising hopes that it could become the first medication for the serious digestive disorder. With celiac disease, the immune system attacks the lining of the smallContinue Reading

WEDNESDAY, June 30, 2021 (HealthDay News) — Could the answer to easing the tough-to-treat chronic pain and fatigue of fibromyalgia be found in edibles and other products containing CBD? A new study from Michigan Medicine examined whether people using potentially addictive painkillers like opioids could get relief by replacing thoseContinue Reading

WEDNESDAY, June 30, 2021 (HealthDay News) — Because they’re often given drugs that suppress their immune systems, people battling a blood cancer known as multiple myeloma have varying responses to the COVID-19 vaccine, new research shows. Some patients had no evidence at all of COVID-fighting antibody production after getting twoContinue Reading

TUESDAY, June 22, 2021 (HealthDay News) — The brains of people who died from COVID-19 were remarkably similar to the brains of people who die from neurodegenerative diseases such as Alzheimer’s and Parkinson’s, showing inflammation and disrupted circuitry, researchers report. “The brains of patients who died from severe COVID-19 showedContinue Reading

THURSDAY, June 3, 2021 (HealthDay News) — Parkinson’s disease patients can get symptom relief with deep brain stimulation (DBS) therapy that lasts over the long term, a new study shows. Over 15 years, patients who received DBS, which requires surgical implantation, had significant improvement in motor symptoms and less needContinue Reading

THURSDAY, May 27, 2021 (HealthDay News) — An experimental antibody therapy may help ease skin symptoms from the autoimmune disease lupus, a small preliminary trial suggests. Researchers found that a higher-dose version of the drug spurred a “clinically meaningful” symptom improvement for 87% of patients after one month. But theyContinue Reading

WEDNESDAY, May 26, 2021 (HealthDay News) — A widely used medicine for autoimmune diseases may lower people’s immune response to the Pfizer mRNA COVID-19 vaccine, a new study suggests. The drug, called methotrexate, is often given to patients with immune-mediated inflammatory conditions such as rheumatoid arthritis and psoriasis/psoriatic arthritis. “OurContinue Reading